- Home
- INMB vs VNRX Comparison
INMB vs VNRX Comparison
Compare INMB & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INMB | VNRX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.3M | 31.9M |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | INMB | VNRX |
|---|---|---|
| Price | $1.20 | $0.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $5.87 | $2.50 |
| AVG Volume (30 Days) | 467.6K | ★ 14.4M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | N/A | ★ N/A |
| Revenue | $14,000.00 | ★ $1,233,511.00 |
| Revenue This Year | $264.29 | $68.22 |
| Revenue Next Year | N/A | $382.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 59.10 |
| 52 Week Low | $1.15 | $0.17 |
| 52 Week High | $11.64 | $0.94 |
Technical Indicators
Market Signals| Indicator | INMB | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 43.05 |
| Support Level | $1.19 | $0.17 |
| Resistance Level | $1.48 | $0.27 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 19.35 | 14.78 |
Price Performance
Historical ComparisonAbout INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.